CELIAC Archives

Celiac/Coeliac Wheat/Gluten-Free List

CELIAC@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Marne Platt <[log in to unmask]>
Reply To:
Marne Platt <[log in to unmask]>
Date:
Sun, 5 Nov 2017 11:28:52 -0500
Content-Type:
text/plain
Parts/Attachments:
text/plain (18 lines)
<<Disclaimer: Verify this information before applying it to your situation.>>

This summary came over my medscape feed (https://www.medscape.com/viewarticle/887758?src=wnl_edit_tpal&uac=285675HZ)- 

NEW YORK (Reuters Health) - A point-of-care (POC) test based on IgA/IgG-deamidated gliadin peptide (DGP) accurately predicts persistent villous atrophy in patients with celiac disease who follow a gluten-free diet, researchers report.



It's not perfect, but it's a step towards reducing the need for duodenal biopsy in those of us who need to monitor villous health. Full article here: http://go.nature.com/2yRxHel 

Thoughts?

Best regards
Marne

*Support summarization of posts, reply to the SENDER not the CELIAC List*
Archives are at: Http://Listserv.icors.org/SCRIPTS/WA-ICORS.EXE?LIST=CELIAC

ATOM RSS1 RSS2